Single agent activity of ZW25, a HER2-targeted bispecific antibody, in heavily pretreated HER2-expressing cancers von Meric-Bernstam, Funda, Beeram, Murali, Mayordomo, Jose Ignacio, Hanna, Diana L., Ajani, Jaffer A., Blum Murphy, Mariela A., Murthy, Rashmi Krishna, Piha-Paul, Sarina Anne, Bauer, Todd Michael, Bendell, Johanna C., El-Khoueiry, Anthony B., Lenz, Heinz-Josef, Press, Michael F., Royer, Nels, Hausman, Diana Felice, Hamilton, Erika Paige

Volltext

Phase I dose escalation study of recombinant interleukin-21 (rIL-21, BMS-982470) in combination with ipilimumab (Ipi) in patients (pts) with advanced or metastatic melanoma (MM) von Bhatia, Shailender, Curti, Brendan D., Gordon, Michael S., Chesney, Jason, Logan, Theodore, Thompson, John A., Royer, Nels, Bittner, Rachel, Fontana, David, Grosso, Joseph, Clemens, Pamela L., Cohen, Lewis J., Ahlers, Christoph Matthias, Wigginton, Jon M., Hwu, Patrick

Volltext